DIXON RICHARD A F 4
4 · ENCYSIVE PHARMACEUTICALS INC · Filed Aug 10, 2005
Insider Transaction Report
Form 4
DIXON RICHARD A F
DirectorSr. V.P. Research & CSO
Transactions
- Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2005-08-08−68,571→ 4,429 totalExercise: $4.38Exp: 2006-03-05→ Common Stock (68,571 underlying) - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2005-08-08−2,857→ 1,572 totalExercise: $4.38Exp: 2006-03-05→ Common Stock (2,857 underlying) - Sale
Common Stock
2005-08-08$12.00/sh−68,571$822,852→ 256,677 total - Sale
Common Stock
2005-08-08$12.00/sh−2,857$34,284→ 256,677 total - Exercise/Conversion
Common Stock
2005-08-08$4.38/sh+2,857$12,499→ 259,534 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2005-08-08−1,572→ 0 totalExercise: $4.38Exp: 2006-03-05→ Common Stock (1,572 underlying) - Exercise/Conversion
Common Stock
2005-08-08$4.38/sh+1,572$6,878→ 258,249 total - Exercise/Conversion
Common Stock
2005-08-08$4.38/sh+68,571$299,998→ 325,248 total
Footnotes (1)
- [F1]Options vest in three equal annual installments beginning on the one year anniversary of the grant date.